LabCompass

Ann-Kathrin Eisfeld

Medicine · The Ohio State University

Mid career · publishing since 2012Rising activity

Publications

31

Citations

907

Est. group size

~10

Recurring co-author estimate

Active years

15

Publishing since 2012

Research summary
AI-generated

Ann-Kathrin Eisfeld's research focuses on the biology and treatment of acute myeloid leukemia (AML) and related blood cancers, including how specific genetic changes affect disease behavior and response to therapy. Recent work has examined combination drug treatments targeting cell survival pathways and cancer cell growth machinery in AML subtypes defined by particular gene duplications. This research is aimed at understanding leukemia at a molecular level to inform more precise treatment strategies.

Acute myeloid leukemia biologyGenetic drivers of leukemiaTargeted drug combination therapiesLeukemia stem cell statesBlood cancer diagnosis and treatment

Publication output was minimal or absent from 2017-2019 and 2022-2023, but has increased notably since 2024, suggesting a recent growth phase in research activity.

Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026

Publication cadence
Publications per year over the last 10 years — averaging 3.8/year recently
1718192020: 3 publications202021: 5 publications2122232024: 7 publications242025: 10 publications10252026: 2 publications26
Publishes in
  • Blood×12
  • Blood Advances×4
  • bioRxiv (Cold Spring Harbor Laboratory)×2
  • Journal of Hematology & Oncology×1
  • Transplantation and Cellular Therapy×1
Similar researchers
By research-topic overlap

This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.

Last updated Jul 19, 2026.

Claim or correct this profile